[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367072-105":59,"doc-detail-367072-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-morf4l1-as-an-endogenous-substrate-of-crbn-and-its-potential-role-as-a-therapeutic-target-in-cancer","Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer","","Ubiquitin-proteasome system dysregulation contributes to hepatocellular carcinoma (HCC) progression and resistance. Cereblon (CRBN), an E3 ubiquitin ligase, modulates protein degradation in response to small-molecule modulators, yet endogenous CRBN substrates in solid tumors remain unclear. This study identifies MORF4L1 as a CRBN substrate and shows that CRBN drives MORF4L1 degradation physiologically, enhanced by CC-885. MORF4L1 is upregulated across cancers, supporting its relevance in tumorigenesis and therapeutic targeting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-morf4l1-as-an-endogenous-substrate-of-crbn-and-its-potential-role-as-a-therapeutic-target-in-cancer/367072/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-morf4l1-as-an-endogenous-substrate-of-crbn-and-its-potential-role-as-a-therapeutic-target-in-cancer/367072.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main biological question addressed in the study?","Question",{"text":112,"@type":113},"The study asks what the endogenous substrates of the CRBN E3 ubiquitin ligase are in solid tumors like HCC and whether they can be therapeutically targeted.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was MORF4L1 identified as a substrate of CRBN?",{"text":117,"@type":113},"Proteomic analysis, co-immunoprecipitation, and structural modeling were used to demonstrate that CRBN promotes MORF4L1 degradation.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does the CRBN modulator CC-885 play?",{"text":121,"@type":113},"CC-885 enhances CRBN-promoted degradation of MORF4L1 under physiological conditions, consistent with CRBN modulator activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367072,1790197113,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of MORF4L1 as an endogenous substrate ofCRBN and its potential role as a therapeutic target in cancer  \nLuyao Zhang1,5, Shunfang Liu2,5, Jingliang He1,5, Zhongke Hu1,5, Lan Zhu3, Hongyi Huang3, Qi Gao1, Dan Wang1, Lu Chen1, Xingyu Zhang1, Ruotong Liu1, Jiayun Wang1, Yizhuo Song1, Kaile Zeng1, Xiuming Li1, Yulu Chen1, Xun Zou1, Shaojie Ma1, Xiujun Wang1, Guofeng Xu4􀀍, Wei Liu3􀀍 & Bin Liu1􀀍  \nThe ubiquitin-proteasome system (UPS) is essential for cellular homeostasis, regulating the degradation of proteins involved in key processes such as cell cycle, apoptosis, and DNA repair. Dysregulation of the UPS is implicated in hepatocellular carcinoma (HCC), contributing to tumor progression and therapeutic resistance. The cereblon (CRBN) E3 ubiquitin ligase complex is a crucial component of the UPS, particularly in modulating protein degradation in response to small-molecule modulators like thalidomide. However, the endogenous substrates ofCRBN in solid tumors like HCC remain poorly characterized. Here, we identify MORF4L1, a member of the MRG family involved in chromatin remodeling and DNA damage response, as a substrate of CRBN. Using proteomic analysis, co-immunoprecipitation, and structural modeling, we demonstrate that CRBN promotes MORF4L1 degradation under physiological conditions, which is further enhanced by the modulator CC-885 . Importantly, MORF4L1 is upregulated in multiple cancers, including HCC, suggesting a broader role in tumorigenesis. Our findings reveal MORF4L1 as a physiological CRBN substrate and highlight the therapeutic potential of targeting CRBN substrates in cancer.  \nKeywords MORF4L1, CRBN, CC-885, Ubiquitin-proteasome system, Hepatocellular carcinoma (HCC), Protein degradation  \nHepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is one of the leading causes of cancer-related deaths worldwide1. Despite progress in treatments such as surgical resection, liver transplantation, and targeted therapies, the prognosis for HCC remains poor, particularly in advanced stages2. This is largely due to late diagnosis, high recurrence rates, and the limited effectiveness of current treatments3. There is, therefore, an urgent need to identify new molecular targets to develop more effective therapies for HCC. The ubiquitin-proteasome system (UPS) plays a crucial role in maintaining protein homeostasis by regulating the degradation of misfolded, damaged, or excess proteins4. By controlling the turnover of key regulatory proteins, the UPS governs essential cellular processes such as cell cycle progression, apoptosis, and DNA repair5. Disruption of the UPSis a common feature in many cancers, including HCC, where it contributes to tumor growth by affecting the stability of proteins that drive cancer cell proliferation and survival6,7. Among the components of the UPS, the cereblon (CRBN) E3 ubiquitin ligase complex has attracted significant attention for its role in directing the degradation of specific proteins in response to small-molecule modulators like thalidomide8–10. The discovery that thalidomide and related compounds, such as lenalidomide and pomalidomide, can alter CRBN’s substrate specificity to promote the degradation of proteins such as Ikaros and Aiolos has led to significant advances in the treatment of multiple myeloma and other blood cancers9, 11, 12. The derivative of thalidomide,  \n1Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China. 2Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Jiefang Road 1095, Wuhan 430030, China. 3Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.  \n4Department of Pediatric Urology, Xinhua Hospital Affiliated to ShanghaiJiao Tong University Sc","cbCaijUVT2q8QxUD","https://ap.wps.com/l/cbCaijUVT2q8QxUD","pdf",2095482,12,"English","# Introduction\n## Background on the ubiquitin-proteasome system and CRBN\n## Therapeutic rationale for identifying CRBN endogenous substrates\n# Results\n## Identification of MORF4L1 as a CRBN substrate\n## CRBN-mediated MORF4L1 degradation under physiological conditions\n## CC-885 enhancement and downstream implications\n# Discussion\n## MORF4L1 upregulation in cancers and therapeutic potential","[{\"question\":\"What is the main biological question addressed in the study?\",\"answer\":\"The study asks what the endogenous substrates of the CRBN E3 ubiquitin ligase are in solid tumors like HCC and whether they can be therapeutically targeted.\"},{\"question\":\"How was MORF4L1 identified as a substrate of CRBN?\",\"answer\":\"Proteomic analysis, co-immunoprecipitation, and structural modeling were used to demonstrate that CRBN promotes MORF4L1 degradation.\"},{\"question\":\"What role does the CRBN modulator CC-885 play?\",\"answer\":\"CC-885 enhances CRBN-promoted degradation of MORF4L1 under physiological conditions, consistent with CRBN modulator activity.\"}]","Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer | PDF",1790169137,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc921f4c458154d74a90326750cd4689.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9863849ae4010c0a6c39f9c8f65afe02.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b34129fbfa1bc2efb09e7c162b30a2ca.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85908d3640879806a7177732dd32e8e6.webp",980,1287]